Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             79 results found
no title author magazine year volume issue page(s) type
1 Abstracts author index 2008
 6 14 p. 152-153
2 p.
 article
2 Accessi venosi centrali: Inquadramento E Idicazioni Maiorino, L.
 2008
 6 14 p. 148-
1 p.
 article
3 Activity and tolerability of Cisplatin (CDDP) and Fotemustine (FTM) combination in the treatment of patients with non-small cell lung cancer (NSCLC) with brain metastases (BM): A multicentric phase II study of the Gruppo Oncologico dell’Italia Meridionale (GOIM) Galetta, D.
 2008
 6 14 p. 151-
1 p.
 article
4 Acute non-lymphocytic leukemia: Onset after treatment for Hodgkin’s disease Santoro, M.
 2008
 6 14 p. 129-130
2 p.
 article
5 Adjuvant chemotherapy of colon cancer current strategies Barone, Carlo
 2008
 6 14 p. 60-63
4 p.
 article
6 A metronomic treatment with oral chemotherapy in patients elderly with metastatic breast cancer Vitello, S.
 2008
 6 14 p. 116-117
2 p.
 article
7 Angiosarcoma of the right atrium: A case report D’Addetta, C.
 2008
 6 14 p. 145-
1 p.
 article
8 Anxiety: A psychological observational study before mammography screening Barni, S.
 2008
 6 14 p. 147-
1 p.
 article
9 Appropriateness of the use of PET/CT in the radiotherapy treatment planning for Hodgkin’s lymphoma Santoro, M.
 2008
 6 14 p. 118-
1 p.
 article
10 Beta-erythropoietin in clinical practice: GOIM 2705 multicenter observational study Addeo, Raffaele
 2008
 6 14 p. 147-
1 p.
 article
11 Bevacizumab+folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell’ Italia Meridionale (prot. GOIM 2601) Giuliani, F.
 2008
 6 14 p. 121-
1 p.
 article
12 Bi-weekly administration of capecitabine+oxaliplatin (XELOX-2) in first line treatment of advanced colorectal cancer (ACRC): Preliminary results Di Bisceglie, M.
 2008
 6 14 p. 120-
1 p.
 article
13 Cetuximab induced cutaneous rash: Does it affect psychological well-being in colorectal cancer patients? Romito, F.
 2008
 6 14 p. 122-
1 p.
 article
14 Chemo-hormonal therapy for metastatic breast cancer patients: Treatment strategy Barni, S.
 2008
 6 14 p. 13-20
8 p.
 article
15 Chemo-radiotherapy in locally advanced rectal cancer: What is the optimal strategy? Avallone, Antonio
 2008
 6 14 p. 70-73
4 p.
 article
16 Circulating tumour cells in colorectal cancer Di Costanzo, Francesco
 2008
 6 14 p. 52-59
8 p.
 article
17 Clinical results of EGFR-targeted therapies in advanced colorectal cancer Maiello, Evaristo
 2008
 6 14 p. 64-69
6 p.
 article
18 Contribution of the functional imaging in the radiotherapy treatment planning for malignant glioma: Revision of the literature Santoro, M.
 2008
 6 14 p. 137-138
2 p.
 article
19 Controversies in adjuvant endocrine therapy for pre- and post-menopausal women with breast cancer Ciccarese, Mariangela
 2008
 6 14 p. 4-9
6 p.
 article
20 Coping with cancer: A prospective psycho-social analysis of cancer patients and their non-medical caregivers (cg) – A goim study Mistretta, G.
 2008
 6 14 p. 141-
1 p.
 article
21 Correlation between basal bilirubin levels and survival in advanced colorectal carcinoma treated with CPT-11-based chemotherapy: A study of the Gruppo Oncologico Italia Meridionale (G.O.I.M.) Colucci, Giuseppe
 2008
 6 14 p. 94-99
6 p.
 article
22 Current challenges and future perspectives in the medical treatment of solid tumours Sobrero, A.
 2008
 6 14 p. 140-
1 p.
 article
23 Current challenges and future perspectives in the medical treatment of solid tumours Sobrero, A.
 2008
 6 14 p. 91-93
3 p.
 article
24 CYR61 down-modulation sensitizes prostate cancer cells to zoledronic acid and docetaxel: A new anti-cancer strategy Caraglia, M.
 2008
 6 14 p. 123-124
2 p.
 article
25 Docetaxel and zoledronic acid combination administered in two different sequences in hormone refractory prostate cancer patients: Phase I clinical study – ZANTE Facchini, G.
 2008
 6 14 p. 124-
1 p.
 article
26 DVD-based group information for cancer inpatients and families Romito, F.
 2008
 6 14 p. 148-149
2 p.
 article
27 Editorial board 2008
 6 14 p. ii-
1 p.
 article
28 EGFR mutations in patients with non-small cell lung cancer (NSCLC) and correlation with sensitivity to erlotinib Ricciardi, S.
 2008
 6 14 p. 134-
1 p.
 article
29 Electrochemotherapy (ECT) for the treatment of superficial tumour metastases Guida, M.
 2008
 6 14 p. 132-
1 p.
 article
30 Epirubicin, taxotere and fluorouracil modulated by folinic acid in the treatment of advanced gastric cancer: A phase II study of the Gruppo Oncologico dell’ Italia Meridionale (GOIM) Giuliani, F.
 2008
 6 14 p. 107-112
6 p.
 article
31 Evaluation of Folfox toxicity in a consecutive series of elderly cancer patients Tambaro, R.
 2008
 6 14 p. 128-
1 p.
 article
32 Experience of 170 cases of ductal carcinoma in ‘ (DCIS) D’Addetta, C.
 2008
 6 14 p. 115-
1 p.
 article
33 First-line cisplatin (P) with docetaxel (TXT) or vinorelbine (VNR) in patients with advanced non-small-cell lung cancer: A phase II randomized trial of Gruppo Oncologico Italia Meridionale Gebbia, V.
 2008
 6 14 p. 151-
1 p.
 article
34 Folfiri versus xeliri in untreated advanced colorectal cancer: A phase II randomised trial of the Gruppo Oncologico dell’ Italia Meridionale (prot. GOIM 2405) Giuliani, F.
 2008
 6 14 p. 120-121
2 p.
 article
35 Gastrointestinal stromal tumours: Two case reports Camplese, P.
 2008
 6 14 p. 119-
1 p.
 article
36 High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: Long term survival data Conti, F.
 2008
 6 14 p. 115-
1 p.
 article
37 High-dose chemotherapy as initial salvage treatment in relapsed testicular cancer patients Morelli, F.
 2008
 6 14 p. 124-125
2 p.
 article
38 Image guided radiation therapy (IGRT) in the treatment planning of prostate cancer: Accuracy and precision of radiation therapy through modern imaging technologies Santoro, M.
 2008
 6 14 p. 125-126
2 p.
 article
39 Imatinib in the treatment of dermatofibrosarcoma protuberans Fattoruso, S.I.S.
 2008
 6 14 p. 145-
1 p.
 article
40 Improvement of pain and psychological status after six months of psychotherapy in cancer patients Tulipani, C.
 2008
 6 14 p. 148-
1 p.
 article
41 Integrated regimen therapeutic (polybiologic-chemotherapy) for melanoma advanced Vitello, S.
 2008
 6 14 p. 135-
1 p.
 article
42 Intravescical Gemcitabine versus Mitomycin for recurrent superficial bladder tumours (stages pTa and pT1): A randomized prospective study Faiola, Vincenzo
 2008
 6 14 p. 124-
1 p.
 article
43 Is mammography screening anxiety related to personal coping style? Bonetti, M.L.
 2008
 6 14 p. 147-148
2 p.
 article
44 Is oral metronomic cyclophosphamide (CTX) an effective palliative treatment for patients with metastatic breast carcinoma (ABC)? experience from a retrospective series of patients Boussen, H.
 2008
 6 14 p. 114-
1 p.
 article
45 Laparoscopy in colon cancer: The new standard? Fumo, F.
 2008
 6 14 p. 100-101
2 p.
 article
46 Making the right choice in the adjuvant chemotherapy of primary breast cancer Lopez, Massimo
 2008
 6 14 p. 10-12
3 p.
 article
47 Malignant pleural mesothelioma: Scheme therapeutic after standard treatment (study of phase II) Vitello, S.
 2008
 6 14 p. 150-
1 p.
 article
48 Management of toxicity in patients treated with tyrosine kinase inhibitors (TKI) Naglieri, Emanuele
 2008
 6 14 p. 42-45
4 p.
 article
49 Merkel cell carcinoma Viola, G.
 2008
 6 14 p. 146-
1 p.
 article
50 Metronomic oral Vinorelbine and Temozolomide, after whole brain radiotherapy, for the treatment of breast cancer patients with brain metastasis. A Phase II study Montella, Liliana
 2008
 6 14 p. 116-
1 p.
 article
51 Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid Marra, M.
 2008
 6 14 p. 79-85
7 p.
 article
52 Molecular biology of renal-cell carcinoma De Luca, Antonella
 2008
 6 14 p. 30-34
5 p.
 article
53 Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients Santini, Daniele
 2008
 6 14 p. 86-90
5 p.
 article
54 Nuovo ruolo degli inibitori dell’aromatasi: Impiego in terapia adiuvante Molino, A.
 2008
 6 14 p. 115-116
2 p.
 article
55 Oligometastases: A new reality in the therapy of the cancer Santoro, M.
 2008
 6 14 p. 139-
1 p.
 article
56 Optimization of the therapeutic index through the integration among target therapy and radiotherapy Santoro, M.
 2008
 6 14 p. 142-144
3 p.
 article
57 Palonosetron for prevention of acute and delayed nausea and vomiting induced by moderately emetogenic adjuvant folfox-4 regimen in colorectal cancer (CRC) patients: A phase II study of the Gruppo Oncologico dell’ Italia Meridionale (GOIM) Giuliani, F.
 2008
 6 14 p. 102-106
5 p.
 article
58 Peritonectomy and intraoperative chemohypertermia as treatment of peritoneal carcinosis: Our experience Camplese, P.
 2008
 6 14 p. 132-133
2 p.
 article
59 Pharmacogenetics in oncology Danesi, R.
 2008
 6 14 p. 74-78
5 p.
 article
60 Pharmacogenetics in oncology Danesi, R.
 2008
 6 14 p. 139-
1 p.
 article
61 Prognostic and predictive factors of breast carcinoma: Beyond hormonal receptors and HER2 Nappi, Oscar
 2008
 6 14 p. 1-3
3 p.
 article
62 Prognostic factors in advanced renal cell cancer Porta, Camillo
 2008
 6 14 p. 35-37
3 p.
 article
63 Radiochemotherapy for anal carcinoma: Our experience Morelli, F.
 2008
 6 14 p. 121-122
2 p.
 article
64 Radiotherapy and temozolomide in glioblastoma: Predictive factors of response to the treatment Santoro, M.
 2008
 6 14 p. 136-137
2 p.
 article
65 Rediscovering immunotherapy in combination with molecularly targeted agents in renal cell cancer Procopio, G.
 2008
 6 14 p. 125-
1 p.
 article
66 Role of positron emission tomography (PET) in advanced stage non-small cell lung cancer patients treated with cisplatin-based doublets Gebbia, V.
 2008
 6 14 p. 150-
1 p.
 article
67 Second-line chemotherapy in advanced cancer of the pancreas: A multicenter survey of the Gruppo Oncologico Italia Meridonale on the activity and safety of the folfiri regimen in clinical practice Arcara, C.
 2008
 6 14 p. 119-
1 p.
 article
68 Second solid cancer after Hodgkin’s disease: Analysis of the risk and revision of the literature Santoro, M.
 2008
 6 14 p. 130-131
2 p.
 article
69 Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study Del Prete, S.
 2008
 6 14 p. 119-120
2 p.
 article
70 Sunitinib in advanced clear cell renal cancer: A single centre experience Bruni, G.S.
 2008
 6 14 p. 123-
1 p.
 article
71 Tamoxifen in the treatment of recurrent, advanced border line ovarian cancer: A single centre experience Pisano, C.
 2008
 6 14 p. 125-
1 p.
 article
72 Target therapy in metastatic renal cell carcinoma Cartenì, G.
 2008
 6 14 p. 38-41
4 p.
 article
73 The burden of renal cell cancer: A retrospective longitudinal study on occurrence, outcomes and cost using an administrative claims database Mantovani, Lorenzo G
 2008
 6 14 p. 46-51
6 p.
 article
74 The delay time in radiotherapy Santoro, M.
 2008
 6 14 p. 142-
1 p.
 article
75 The role of bevacizumab in breast cancer Daniele, Gennaro
 2008
 6 14 p. 26-29
4 p.
 article
76 Toward a new prognostic-therapeutic index in geriatric oncology Bellavia, M.
 2008
 6 14 p. 127-128
2 p.
 article
77 Treatment in metastatic prostate cancer with hormone refractory Vitello, S.
 2008
 6 14 p. 1-
1 p.
 article
78 Treatment of HER-2 positive breast cancer Clavarezza, Matteo
 2008
 6 14 p. 21-25
5 p.
 article
79 Upfront aromatase inhibitors (AI) in early breast cancer: Against Boccardo, F.
 2008
 6 14 p. 113-114
2 p.
 article
                             79 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands